Childhood ADHD May Raise Risk for Later Psychotic Disorder
MONDAY, March 1, 2021 -- A childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) is associated with an increased risk for a subsequent psychotic disorder, according to a review published online Feb. 24 in JAMA Psychiatry.
Mikaïl Nourredine, M.D., from Hospices Civils de Lyon in France, and colleagues conducted a systematic literature review to identify studies exploring the association between ADHD (diagnosed before 18 years of age) and the risk for subsequent psychotic disorder.
Based on 12 pooled studies (1.85 million participants), the researchers found that a diagnosis of ADHD in childhood was associated with a significant increase in the risk for subsequent psychotic disorder, with a pooled relative effect of 4.74. There were no significant between-group differences observed in subgroup analyses based on psychotic disorder (odds ratio [OR], 5.04) or schizophrenia (OR, 4.59) outcomes. Results were similar by study design (cohort: OR, 4.64; case-control: OR, 6.81), as well as in adjusted (OR, 4.72) and unadjusted (OR, 3.81) analyses.
"Further studies are required to determine the mechanisms linking these common conditions and whether early intervention for ADHD might reduce the risk of subsequent psychotic disorder," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
THURSDAY, March 25, 2021 -- Hypertensive disorders of pregnancy (HDP) are associated with modestly increased risks for autism spectrum disorders (ASDs) and possibly...
WEDNESDAY, March 3, 2021 -- Self-reported symptoms of behavioral health issues remain high as the COVID-19 pandemic continues, according to a research letter published online Feb....
MONDAY, March 1, 2021 -- There are racial and ethnic disparities evident in the diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD), according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.